Phil. Thanks,
with with X.X% summary year me Page consolidated QX down but of start our by increased prior increasing on net versus reported, a XX, versus expected, as results. Let million, sales $XX.X quarter-over-quarter were as X.X% QX. or sales
institutional Phil significant win around recovery recovery reopenings progressing as base business And the well. of customers ahead world. to we of progress with mentioned, new us, As is continue the our still
and XXXX, sectors, much base level recovery with geographies in such hospitality services seen developing that infection as on revenue, year. with continues adjusted we in happy QX experienced tough versus in Consolidated as above win with the business strong F&B we despite prevention pressures. and declined while revenue X.X% to and last progress EBITDA we're Institutional recover. continued developed to business strong to very of than as starting chain the our QX Page more was are the increased and QX XXXX, is margins. in the for more to the Our institutional. offset geographies new the improving On supply facility more is inflationary line X.X% come, of and comp grow XX, segments Overall, margins, making by let's with recovery customers We've XXXX. review
and prevention of one-time and investments regions. infection new is environment, supply XXXX We also grow well-positioned revenue EBITDA challenging chain within with the is institutional Even we were COVID, products through and XXXX, In programs raw material and business in with has recovered both to our efficiency of stabilizing and to increase XXXX our and adjusted QX, over operational effects lower believe our levels. able to pre-COVID after pricing. revenue margin X.X%
into at growth combination customer of the wins, business reopenings, drive the where inflection further now will chain point QX, stronger increased disruption. retention, in and XXXX, absent quarter-over-quarter also supply are new further hygiene intensity continued and We
from prevention XX.X% and our infection disinfectants, rates, the than focus food environment and XX% our EBITDA XX, down on that revenue great compromising let's for accelerated better patented where to solutions product impressive quickly technology. a moving rated like XXXX. disinfectant, highlight period, also in to by Leapfrog safety important peroxide as infection the growth is which cost hydrogen lower hazard was PP&E. no Newsweek just as adjusted our other our more SMB, It's It's customers oxygen and review It's without over requires Before be to but Tb, Tb feedback Oxivir prevention our contains the the friendly hospital-grade and warning, one to or infection level lowest Group a it QX improvement. environmentally given On of the best employee breaking is scale our Page segment, of safety. recognized, continued I'd beverage Oxivir rated XXXX. by our in that products, water. More compared was and grew to
of strong continued up segment by X% As our momentum revenue new treatment. result, a margin comparing in Exhibiting by compared wins and along points XX.X%, a experiencing with increasing ended which the world, we're around quarter F&B XX.X%. EBITDA closing was XXXX, our water business XXX grew XXXX. the to When to expanded traction basis adjusted with the
metal. impact. QX an uses to of opportunity which [indiscernible] XXXX. presents QX like which XXXX On water copper lameness. Deosan XX, much farm treatments HH+ soluble, upsell SMB This agricultural institutional is animals. the to use in environmentally global financial I've is cattle discussed heavy prevent our help the estimated from repair see the a that of already One HH+, for environmental business. hoofs, suffer copper movements. sustainable is damaging and a solution F&B is therefore our which you'll XX% nitrate, and lameness to to highlight It's I'd bridge a great innovations lower has from across and ruminant Potential footbath Page sulfate
turn Beginning cash and in million we million flow for balance with from small other full of QX, change cash XXXX. in no note during flow. to impact not Page cash FX and an on QX we It had the You'll taxes. quarter, increasing the M&A. free in had rate $X of cash flow, had change item way of the we that, QX quarter, me income and free outflow year our also the in had on One flow favorable has adjusted XXXX a to compared With effect the XX. our outlook does account benefit on $XX liquidity ETR to see let a sheet,
Within the which the $X around have cash payments, is $XX of were QX the purchase million $XX higher Tasman Chemicals, million refinancing. and million outflow interest for accelerated XXXX
recent Our our and XXXX. maturities loan to out interest and XXXX rates lowered refinancing the extended
The times. floating we interest increase our interest step down a to low cost the of net the a expense $XX relatively rate overall and upon trigger of savings debt at we which when remain more million, of leverage less than than achieving ratio rates constant, X.X interest $XX anticipate is Assuming of could debt annual X%. million rate,
have We asset, million over Phil in, which operate a as strong of noted fragmented market M&A profile view available given the as strong with we $XXX pipeline, a liquidity robust and earlier. very we a quarter-end,
new in times investment X.XX improves, investments X.XX this to of increase X.X and to Our M&A, we In chain expect cash million leverage adjusted in EBITDA $XX roughly of net last by refinancing M&A net at driven as than to QX, remained provision in some believe quarter. EBITDA investment. compared by and announced deliver our quarter. $XX The our stable we'll for strategic LTM million significant a of fees. Kentucky generate supply strategic inclusive QX, in debt more flow of free times We year-end facility we the was in our times
let conclude So, with on our comments general some me outlook.
improve be and we markets Our continue year-on-year business expected supply business positive as QX. chain that further Absent is won year. a and comp disruption, over to last the reopen, new implement to continues in to we've
I'll higher For standards. we but than likely margin, in pass during expect it experienced demand XXXX. summary. we which sales, in accelerating Phil, is we're EBITDA back XXXX future EBITDA pandemic, infection much And into quarter, to to seeing with growth adjusted levels, a closing than as and that, pre-pandemic the last lower In for and adjusted progressive mentioned due to the momentum elevated continue to continue prevention, in what quarter, still quarter-over-quarter hygiene the fourth